Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

404 trials

NCT05258396
Recruiting
Exploring Cortical Remyelination in Children With Multiple Sclerosis
Not applicable · France · 3 sites
Registry update: 6 Mar 2026
NCT06329453
Recruiting
Intestinal Immunity in Neurologic Disease
Not applicable · United States · 1 site
Registry update: 27 May 2026
NCT04819737
Recruiting
Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences
Not applicable · Switzerland · 1 site
Registry update: 5 Mar 2026
NCT05170126
Recruiting
A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring
Not applicable · Germany, United States · 3 sites
Registry update: 20 Nov 2025
NCT05357781
Recruiting
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
Not applicable · Switzerland · 1 site
Registry update: 1 May 2026
2024-513960-24-00
Recruiting
Effects of ozanimod on myelin dynamics and neurodegeneration in patients with relapsingremitting multiple sclerosis: correlation with disease activity, cognition, fatigue,depression and quality of life
Phase 4 · Italy · 1 site
Registry update: 24 Jun 2026
NCT05787795
Recruiting
Identifying and Characterizing Preclinical MS
Not applicable · United States · 1 site
Registry update: 27 Aug 2026
NCT05493514
Recruiting
Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System
Not applicable · Italy · 1 site
Registry update: 9 Aug 2022
NCT05344469
Recruiting
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
Not applicable · Germany · 100 sites
Registry update: 30 Jul 2026
NCT05982925
Recruiting
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Not applicable · United States · 1 site
Registry update: 15 Jun 2026
NCT05388331
Recruiting
RIS International Cohort
Not applicable · France · 1 site
Registry update: 24 May 2022
NCT05269628
Recruiting
Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
Phase 2 · United States · 1 site
Registry update: 17 Jul 2026
2024-518374-13-00
Recruiting
Effect of siponimod on relevant imaging and immunological hallmarks of progressive multiple sclerosis
Phase 4 · Italy · 2 sites
Registry update: 5 Nov 2024
NCT04873492
Recruiting
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
Not applicable · France · 1 site
Registry update: 19 Mar 2026
NCT05147532
Recruiting
Remyelination in Multiple Sclerosis: a PET-MR longitudinal study investigating individual profiles of myelin repair and the contribution of neuroinflammation (SMART in MS)
Phase 3 · France · 3 sites
Registry update: 23 Oct 2026
NCT05054140
Recruiting
Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients with Progressive Multiple Sclerosis
Phase 2 · Bulgaria, Czechia, Germany, Netherlands, Poland, Romania · 41 sites
Registry update: 23 Oct 2026
NCT04933552
Recruiting
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
Not applicable · United States · 1 site
Registry update: 16 May 2024
NCT04573673
Recruiting
Transcutaneous Tibial Neuro-stimulation to Improve Voiding Dysfunction in Multiple Sclerosis.
Not applicable · France · 1 site
Registry update: 23 Dec 2025
NCT04458688
Recruiting
Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
Not applicable · United States · 1 site
Registry update: 6 Jun 2022
NCT05204459
Recruiting
MS-ResearchBiomarkerS
Not applicable · United States · 1 site
Registry update: 6 Feb 2024

Ordered by registry start date. Freshness and sponsorship never change the order.